• CONCLUSION: SMILE and FS-LASIK are comparable in efficacy, safety and predictability for correcting myopia.
INTRODUCTION
F emtosecond laser in situ keratomileusis (FS-LASIK) has been the most common corneal refractive surgery and has proved to be effective, safe and predictable for treating myopia [1] . However, there is some problems to limit the application of FS-LASIK, which includes the risk of flaprelated complications and dry eye [2] [3] . Small incision lenticule extraction (SMILE) becomes a new option for myopic patients and the corneal flap production is replaced by removing the corneal stroma lenticule from a minimized incision to reduce the complications of corneal flap and dry eye since 2011 [4] [5] . Recent studies have indicated that there is less impairment of the biomechanical effects and more corneal nerves are preserved when treated with SMILE compared with FS-LASIK because of the complement of the anterior cornea, which can reduce the incidence of dry eye [6] [7] [8] . However, there is no wavefront-guided individual treatment to reduce the production of aberration in SMILE. Recent clinical studies have contrasted some pros and cons between SMILE and FS-LASIK to treat myopia [9] [10] [11] [12] [13] , but there were several different conclusions regarding the postoperative visual quality between the two procedures, especially in terms of the biomechanical effects [9, [14] [15] [16] . Currently, several
Meta-analyses have only investigated the clinical outcome differences in visual acuity and dry eye between SMILE and FS-LASIK [17] [18] [19] , which is insufficient for the evaluation of the two types of surgeries. Therefore, the purpose of our study was to review mass of relative literatures for exploring the benefits in visual acuity, aberration, biomechanical effects and contrast sensitivity between SMILE and FS-LASIK.
MATERIALS AND METHODS
We conduct the Meta-analysis in accordance with a prepared protocol, following the generally accepted recommendations [20] [21] . Search Strategy Two reviewers independently searched PubMed, EMBASE, Cochrane, Web of Science and Chinese databases (WANFANG and CNKI) up to November 20 th ,
2016. The search keywords were included: "myopia", "smallincision lenticule extraction" or "SMILE" and "FS-LASIK" or "femtosecond" or "laser in situ keratomileusis". No date or language restrictions were used for the research. We scanned the titles and abstracts, retrieved relative full studies and involved the articles in accordance with our inclusion criteria.
Any disagreement between the reviewers was resolved by discussion.
Inclusion Criteria
The following selection criteria was included: 1) prospective randomized controlled trials (RCTs) and nonrandomized comparative trials; 2) adults with any degree of myopia or myopic astigmatism without systemic or ocular disease; 3) patients treated with the corneal surgery (SMILE or FS-LASIK); 4) the follow-up period no less than 3mo; 5) original clinical articles with independent data was selected.
Outcome Measures
The primary outcome parameters were efficacy, safety, and predictability. The efficacy measure was the proportion of eyes achieving an uncorrected visual acuity (UCVA) of 20/20 or better. The safety measures were the percentage of eyes losing one or more lines of best spectacle corrected distance visual acuity (BSCVA) and the postoperative spherical equivalent (SE). The refractive SE within ±1.00 diopter (D) of the target refraction was as the measure of predictability. The secondary outcomes were aberration, biomechanical effects and contrast sensitivity. Aberration included total higher-order aberration (tHOA), spherical aberration, horizontal coma and vertical coma, and biomechanical effects included corneal hysteresis (CH) and corneal resistance factor (CRF). The follow-up period ranged from three to six months, and data were extracted and analyzed from the included studies.
Data Extraction and Quality Assessment
The data extraction and quality assessment were independently finished by two reviewers, and the following information was extracted: the first author, design, year, country, enrolled eyes number, preoperative SE, follow-up time and scores of assessment. The Jadad scale [22] was used to assess the RCTs, while the Newcastle-Ottawa scale (NOS) [23] was adopted to evaluate the cohorts. Randomization, blinding, and participant withdrawal/ dropout were the parameters of the Jadad scale, and the scores of Jadad scale ranged from minimum of 0 (low quality) and maximum of 5 (high quality). Each one point was allocated for the parameters of the Jadad scale respectively and additional one point was obtained when randomization and blinding were appropriate. The NOS contains the following three main areas of assessment: selection quality, comparability, and outcome measures. The study was considered high quality when scoring >3 points in the Jadad scale or scoring >6 points in the NOS.
Statistical Analysis
The Meta-analysis was completed with the RevMan software (version 5.2). The mean difference (MD) was used for continuous outcomes, and the odds ratio (OR) was calculated for dichotomous outcomes. The corresponding 95% CI was used for summary estimates, and statistically significant was a P<0.05. The Chi-square and I 2 statistics were used to assess heterogeneity.
The fixed effect model (FEM) was used without significant heterogeneity. However, the random effect model (REM) was used when heterogeneity was obvious (P<0.10 or I 2 was >50%). The robustness of the results was evaluated with sensitivity analysis, which was performed by excluding the individual studies one by on to assess its influence on the pooled estimation. Begg's and Egger's tests were adopted to estimate publication bias using STATA [24] [25] (version 12.0).
RESULTS

Search Results
A total of 201 relative studies were selected through the electronic databases. After titles and abstracts were screened, 123 studies were excluded and 19 studies were found ineligible for inclusion after a systematic review. Finally, 2 RCTs [10, 12] and 25 cohorts [7, 9, [13] [14] [15] [16] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] were involved. The reasons to exclude studies were as follows: 2 studies did not have qualifying interventions, 1 study did not have measurable outcomes, 2 studies were simple letters or commentaries, 3 studies were experiments, 5 studies were duplicates, and 6 studies did not consist with inclusion criteria. Study Characteristics and Quality The characteristics and the quality assessment of the included studies were summarized in Tables 1, 2 . A total of 4223 eyes were included, of which 1928 eyes (45.65%) treated with SMILE and 2295 eyes (54.35%) treated with FS-LASIK. The randomization measures that were used were inadequate in the RCTs [10, 12] , and there was no blinding of the surgeons or patients. When compared with non-randomized cohort studies, the following factors were not significantly different between groups within the studies: age, gender, preoperative SE, aberration, CH or CRF [7, 9, [13] [14] [15] [16] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] . Only eleven studies had six months of followup [7, 9, [14] [15] 28, 30, 33, [37] [38] [39] 44] . Therefore, both RCT studies were considered low quality (scoring<3) according to the standard of Jadad scale, and twenty-four non-randomized comparative studies scored of high quality (NOS≥6) except for Shen et al [42] 2014 (NOS=5). better, and no significant differences were found between the SMILE and FS-LASIK groups within 6mo (OR 0.77; 95% CI: 0.54, 1.09; P=0.14; Figure 1 ) [10, [12] [13] 15, 31, [35] [36] . Losing one or more lines of best spectacle-corrected visual acuity Seven studies reported no significant differences were found in the percentage of eyes losing one or more lines of BSCVA between the two groups at the end of follow-up time (OR 1.22; 95% CI: 0.74, 2.03; P=0.43; Figure 2 ) [10, 13, 15, 27, 31, 36, 44] . Postoperative mean refractive spherical equivalent Eleven studies indicated there was no significant difference of the postoperative mean refractive SE outcomes between SMILE and FS-LASIK groups (MD 0.00; 95% CI: -0.04, 0.05; P=0.89; Figure 3 ) [10, [12] [13] 27, 30, [34] [35] [36] [37] [41] [42] .
Primary Outcomes
Postoperative refraction within ±1.0 D of the target refraction
Six studies reported no significant difference was found in the postoperative refraction within ±1.0 D of the target refraction between SMILE and FS-LASIK groups (OR 0.91; 95% CI: 0.43, 1.93; P=0.80; Figure 4 ) [10, 13, 27, 31, 36, 44] .
Secondary Outcomes Aberration
Ten studies reported the postoperative aberration at the follow-up times within 6mo. The forest plot showed that tHOA (MD -0.47; 95% CI: -0.61, -0.33; P<0.00001; Figure 5 ) [16, 26, 28, 31, 33, 39, [43] [44] and spherical aberration (MD -0.64; 95% CI: -0.88, -0.39; P<0.00001; Figure 6 ) [10, 16, 26, 28, 31, 33, [39] [40] [43] [44] were lower in the SMILE group than that in FS-LASIK. No significant difference was found in either the horizontal coma (MD 0.11; 95% CI: -0.06, 0.28; P=0.19; Figure 7 ) [10, 16, 26, 28, 33, 40, [43] [44] or the vertical coma (MD -0.10; 95% CI: -0.36, 0.16; P=0.45; Figure 8 ) [26, 28, 33, 39, 43] between the two groups. A sensitivity analysis was conducted because of the apparent heterogeneity Hu et al [27] CT Lin et al [40] CT (prospective) 2013 China 33 -4.81±1.47 37 -5.56±2.08 3 -7
Lin et al [13] CT (prospective) 2014 China 60 -5.13±1.75 51 -5.58±2.41 3 -7
Denoyer et al [37] CT ( Wang et al [14] CT (retrospective) 2016 China 50 -7.60±1.12 56 -7.68±1.19 3 -7
Sefat et al [41] CT (prospective) 2016 Germany 43 -3.81±0.95 26 -3.65±1.12 3 -6
Wu et al [7] CT (prospective) 2014 China 40 -5.71±1.19 40 -5.80±1.14 6 -8
Li et al [30] CT (retrospective) 2014
Li et al [28] CT (prospective) 2014 China 72 -6.04±1.80 70 -5.94±1.73 6 -8
Li et al [38] CT ( Li et al [29] CT (retrospective) 2016 China 40 -7.89±0. 87 40 -7.31±0.66
Ye et al [33] CT (retrospective) 2014 China 170 -5.03±1.89 88 -5.43±2.32 6 -8
Shen et al [42] CT ( Ang et al [35] CT (prospective) Li et al [39] CT (retrospective) 2015 China 55 -5.74±1.39 51 -6.18±1.61 6 -8
Zhang et al [34] CT ( Chan et al [36] CT (prospective) 2016 China 54 -5.23±1.96 57 -5.82±2.60 3 -7
Qiao et al [31] CT (prospective) 2015 China 188 -5.24±1.85 184 -5.24±1.72 3 -7
Wu et al [32] CT (prospective) 2015 China 34 -6.86±0.84 29 -7.20±0.82 3 -7
Xia et al [15] CT (prospective) 2016 China 69 -5.04±2.32 59 -5.13±1.36 6 -8
Agca et al [9] CT (prospective) 2014 Turkey 30 -3.62±1.79 30 -3.71±1.83 6 -8
Liu et al [10] RCT Figure 9 ) and CRF (MD 0.67; 95% CI 0.38, 0.96; P<0.00001; Figure 10 ) between the two groups. The exclusion of the Agca et al [9] made I 2 reduce from 69% to 40%, but did little influence on the results of CRF (MD 0.48; 95% CI: 0.21, 1.27; P=0.02).
Contrast sensitivity Four studies reported changes in contrast sensitivity after SMILE and FS-LASIK [10, 12, 40, 44] . Liu et al [10] indicated that the contrast sensitivity recovered to the preoperative level later in the SMILE group than that in FS-LASIK. Regarding the follow-up time, several reports [40, 44] suggested that contrast sensitivity was better in the SMILE group than in FS-LASIK, particularly at higher spatial frequencies [12] . The changes in contrast sensitivity are presented in Table 3 . Publication Bias No publication bias was apparent using Begg's tests (P=0.142 to 0.881) and Egger's test (P=0.106 to 0.926) ( Table 4) .
DISCUSSION
In this Meta-analysis, SMILE achieved similar efficacy, safety and predictability as FS-LASIK within a 6mo follow-up time, and the outcomes of horizontal coma and vertical coma were not significantly different between the two surgeries. Additionally, the increase in tHOA and spherical aberration in the SMILE group was lower than that in the FS-LASIK group. In addition, the decrease in the CH and CRF was greater in the FS-LASIK group compared with the SMILE group, which aided in the investigation of the fewer impact of biomechanical effects in the SMILE group. Most studies demonstrated that the contrast sensitivity in SMILE was superior to that in FS-LASIK. Currently, three Meta-analyses have been published, all of which focused on efficacy, safety, predictability, dry eye and central corneal sensitivity. Therefore, our study is the first study to compare the clinical outcomes of aberration, biomechanical effects and contrast sensitivity between the [26] 3 2 2 7
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The total scores of NOS ranged from minimum of 0 (low quality)
and maximum of 9 (high quality), basing on the following standards:
patient selection methodology (points ranged from 1 to 4), comparability of the study groups (points ranged from 1 to 2) and outcomes measures (points ranged from 1 to 3). SMILE and FS-LASIK techniques using a Meta-analysis with more related studies included. Because of the differences in the details of the reviewed studies, we had difficulty in extracting data and summarizing the data. We included all data that were consistent with our inclusion criteria and interpreted the clinical outcomes.
When heterogeneity was observed among the studies, a sensitivity analysis was conducted. In addition, we used Begg's rank correction test and Egger's linear regression test to determine the publication bias. A major difficulty was the different measurements of aberration, biomechanical effects and contrast sensitivity. When detecting aberration and biomechanical effects, these studies used a different wavefront analyzer or biomechanical instrument, which may account for the significant difference. Therefore, we selected the parameters of the whole cornea aberration at 6 mm in diameter and the ocular response analyzer for the biomechanical effects. Another difficulty was the diverse variation in the follow-up times. According to our clinical experience and the associated study [18] , the parameters of efficacy, safety, predictability, aberration and biomechanical effects are stable at least three months postoperatively. Thus, the follow-up time of the Metaanalysis was conducted within 6mo. This Meta-analysis suggested that both SMILE and FS-LASIK are effective, safe and predictable. In terms of efficacy, an examination of the forest plot revealed that no significant differences were detected between the SMILE and FS-LASIK groups relative to the proportions with uncorrected distance visual acuities of 20/20 or better. The I 2 value of UCVA indicated that heterogeneity was not observed among the studies and that the results were analyzed using a fixed effects model. Ang et al [35] and Liu et al [10] suggested that the results of proportions with uncorrected distance visual acuities of 20/20 or better in the FS-LASIK group were better than in the SMILE group during the 3mo to 6mo, which may be due to the difference in the healing response between both procedures.
Agca et al [45] reported that eyes treated SMILE have increased corneal backscatter in the interface 3mo after extracted lenticule surgery compared with the FS-LASIK procedure.
In terms of safety, the proportion of eyes losing one or more lines of corrected distance visual acuity in the SMILE group was similar to those in the FS-LASIK group, which suggested that both SMILE and FS-LASIK are safe concerning correction of refraction.
In terms of predictability, we assessed the postoperative mean refractive SE and the proportion of postoperative refraction within ±1.0 D of the target refraction and no significant differences were found between the two groups. Additionally, Ganesh demonstrated that SMILE has greater predictability than FS-LASIK because the refractive lenticule was cut by a femtosecond laser in SMILE rather than by lifting the flap and exposing the stroma in FS-LASIK, which may reduce hydration changes of corneal stroma in SMILE [46] [47] . Visual quality is not only visual acuity but also includes aberration and contrast sensitivity. The refractive surgeryinduced aberration increased after the surgery following up time point of 6mo. The increasing of tHOA and spherical aberration occurred more in the FS-LASIK group than in the SMILE group. However, there was not an apparent difference in horizontal coma and vertical coma between two groups. Controversially, Wu and Wang [43] reported that the vertical coma was significantly increased after the SMILE surgery, whereas the horizontal coma was significantly increased after FS-LASIK surgery. The postoperative spherical aberration was associated with optical and ablation zones [48] . There is no transition zone for the SMILE procedure, and it achieves a larger ablation zone than the FS-LASIK procedures, which indicated that spherical aberration was lower in SMILE group than that in FS-LASIK group. With regard to the induction of coma, imbalanced corneal healing responses and imbalanced optical changes along the axis were involved [49] . Several studies [50] [51] demonstrated that the induction of coma was Ganesh et al [12] Measured using the FACT chart
At day 1, contrast sensitivity was better in FS-LASIK group than SMILE group at the 1.5, 3, 6, 12 and 18 cpd , but by 15d and 3mo, contrast sensitivity was better in SMILE group than FS-LASIK group, particularly at higher spatial frequencies (18 cpd).
Lin et al [40] Measured using the CGT-1000
Contrast sensitivity was better in SMILE group than FS-LASIK group at the 1.0, 1.7, and 4.2 cpd without glare and at 2.6, 4.2 and 6.6 cpd with glare after 1mo. And it was better in SMILE group than FS-LASIK group at the 1.7 and 4.2 cpd without glare and at 1.7 cpd with glare after 3mo.
Xu and Yang [44] Measured using the CGT-1000 Contrast sensitivity was better in SMILE group than FS-LASIK group at 6mo postoperatively.
Liu et al [10] Measured using the CSV-1000E
In the SMILE group, the contrast sensitivity at spatial frequencies of 3 cpd and 6 cpd under different lighting conditions recovered to the preoperative level at 1wk postoperatively, but 12 cpd and 18 cpd recovered to the preoperative level at 1mo postoperatively. In the FS-LASIK group, the contrast sensitivity at spatial frequencies of 3, 6, 12, and 18 cpd under different lighting conditions recovered to the preoperative level at 1wk postoperatively caused by decentrations after the SMILE surgery. Whereas, another study [43] reported that weaker wound healing responses occurred in the SMILE group. In brief, more research and further studies are needed to investigate the change of aberration when comparing SMILE with FS-LASIK. Furthermore, the I 2 value of spherical aberration, horizontal coma and vertical coma all showed significant heterogeneity among studies. Thus, a sensitivity analysis was performed, and the results were evaluated using a random effects model. For spherical aberration and vertical coma, the results were analyzed by excluding one study at a time and demonstrated that the heterogeneity did not change and the results of the previous analysis were stable. When excluding Li et al [39] , the I 2 value decreased, but there was no significant change in the estimated value, which may have been caused by measurement bias.
The refractive surgery-induced biomechanical effects decreased after surgery demonstrated by six reports [9, [14] [15] [16] 38, 43] . The data showed a smaller decrease of CH and CRF in the SMILE group than in the FS-LASIK group within 6mo after surgery. Nevertheless, there was significant heterogeneity in CRF by assessing the I 2 value. Sensitivity analysis revealed that the study by Agca et al [9] was the source of statistical heterogeneity in the Meta-analysis for the CRF, but the exclusion of the study did not significantly reduce heterogeneity. Agca et al [9] involved patients with low to moderate myopia, however, other studies included moderate to high myopia. However, there is no evidence to identify the correlation between the degree of myopia and the change of biomechanical effects between two groups. Moreover, Wang et al [14] reported that there was a significant difference between SMILE and FS-LASIK (P=0.096) at the 6mo followup, although there was no statistically significant difference in CH. The study of Wang et al [14] can sharply increase the heterogeneity among these studies (I 2 from 0 to 94%) and is the reason for excluding the study. Several clinical studies [15] [16] 43] and mathematical analyses [52] [53] demonstrated that the SMILE procedure was superior to the FS-LASIK surgery with respect to the corneal biomechanics. Otherwise, another study [9] found similar biomechanical effects between SMILE and FS-LASIK surgery. Biomechanically, the flapless lenticule extraction technique maximally protects the structural integrity of the cornea and causes less disruption of the peripheral collagen fibers than LASIK [7] . Theoretically, the degree of wound repair is correlated with the inherent strength of the corneal tissues [54] . An in vivo study [55] found that refractive lenticule extraction might result in less inflammation and early extracellular matrix deposition than LASIK. In consideration of contrast sensitivity, it is known that contrast sensitivity is lower after undergoing SMILE and FS-LASIK surgery. Several studies [12, 40, 44] indicated that contrast sensitivity was better in SMILE group than that in FS-LASIK group except the report of Liu et al [10] . Liu et al [10] reported that the speed of recovery of contrast sensitivity was due to the different mechanisms of the corneal stromal wound-healing process after both procedures at high spatial frequencies under different lighting conditions. Furthermore, several previous studies have suggested that the decrease in contrast sensitivity was associated with the increase in HOAs [56] [57] .
However, Stonecipher and Kezirian [58] found that there was no relationship between contrast sensitivity and HOAs. There are several important limitations in the Meta-analysis. First, most of the studies were from Asia, which may cause publishing bias. Second, extracted data of aberration included various measurements from different wavefront analyzers, which increased the method bias.
In conclusion, SMILE and FS-LASIK are comparably safe, effective and predictable when used for the treatment of myopia. Postoperative aberration and a decrease in biomechanical effects may occur less frequently after SMILE than after FS-LASIK. Contrast sensitivity was better in the SMILE group than in the FS-LASIK group 3-6mo postoperatively.
Further randomized, double-blinded, prospective studies with longer follow-up periods are warranted to provide a better understanding of the benefits of SMILE and FS-LASIK.
